Skip to main content
Sister Publication Links
  • ESG: THE NEW IMPERATIVE
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • COVID-19
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Transformation
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Digital Health
  • Insights
    • ACA 10 Years After
    • Best Practices
    • Special Reports
    • Innovations
  • Opinion
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top 25 Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Supply Chain
    • - Hospital at Home
    • - Workplace of the Future
    • - Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
  • Data Center
    • Data Center Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • MORE +
    • Contact Us
    • Advertise
    • Media Kit
    • Newsletters
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Law & Regulation
October 18, 2022 02:28 PM

Feds probe Walgreens, CVS over withheld prescriptions post-Roe

Crain's Chicago Business
Katherine Davis
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    wag pharmacy.jpg
    Bloomberg

    Walgreens Boots Alliance, CVS and other pharmacy chains are being investigated by the U.S. Department of Health & Human Services after the agency received complaints about pharmacists not filling prescriptions for medications that could harm a pregnancy.

    HHS Secretary Xavier Becerra tweeted a USA Today article Oct. 14 about Illinois-based Walgreens and CVS pharmacists withholding medications from customers, writing: "Since Dobbs & state laws that have gone into effect, HHS has received complaints about chain pharmacies across the U.S. for not complying w/ their federal obligations to fill prescriptions.” The HHS’ Office for Civil Rights “has opened investigations into these companies & others,” he said in the tweet.

    The investigation comes about four months after the Supreme Court overturned Roe v. Wade, the landmark decision that gave women the right to an abortion. Now laws vary state to state, with some outlawing access to abortion under nearly all circumstances. In Illinois, abortion remains legal.

    Read more:
    Beyond the Byline: Roe v. Wade ruling compromises patient safety
    Supreme Court abortion ruling has big ramifications for providers

    Since the ruling, and as pharmacies have navigated new laws in some states, reports have emerged of pharmacists at Walgreens and CVS locations denying patients contraceptives, as well as methotrexate, a treatment for rheumatoid arthritis and osteoporosis that can also end ectopic pregnancies, and misoprostol, a stomach ulcer medication commonly prescribed before IUD insertions.

    The controversy has led to public complaints for both companies. For Walgreens, complaints led to the hashtag #BoycottWalgreens trending on Twitter in July. Not even two weeks later, Illinois Sens. Dick Durbin and Tammy Duckworth put pressure on Walgreens to revise a policy they said allows Walgreens employees to refuse to sell contraceptives to customers based on workers' religious or moral beliefs.

    Walgreens previously told Crain’s it allows employees to refuse to sell contraceptives to customers if it conflicts with their personal beliefs, and the workers are required to refer customers to another employee who can complete the transaction. The policy abides by federal law under the Civil Rights Act of 1964, which prohibits employment discrimination based on religion, race, color, sex and national origin, Walgreens said.

    In a statement today, Walgreens spokesman Fraser Engerman said the company is cooperating with the HHS’ investigation about complaints at its stores.

    “We have taken steps to comply with applicable laws,” Engerman said. “Our pharmacists will continue to work closely with prescribers as necessary, to fill lawful, clinically appropriate prescriptions. Our top priority is ensuring our patients have access to the medications they need from pharmacists they know and trust.”

    Download Modern Healthcare’s app to stay informed when industry news breaks.

    Walgreens had about 8,965 stores as of Aug. 31, and filled 1.2 billion prescriptions in 2021, according to its website.

    Woonsocket, R.I.-based CVS did not answer Crain’s questions about its policy today, but reportedly has a policy similar to Walgreens'.

    CVS, which has more than 9,900 retail locations in all 50 states, nearly 70 of which are in Chicago, said in a statement to Crain’s that it’s committed to supporting women’s healthcare.”

    “Our highest priority is ensuring safe and timely access to medications. However, laws in select states restrict the dispensing of medications that may be prescribed for the purpose of inducing an abortion. Our pharmacists, like other healthcare providers, are caught in the middle on this issue. In certain cases, they may face criminal charges for dispensing medications for this purpose. We will cooperate with any government inquiry on this complex issue.”

    CVS manages and fills about 2.5 billion prescriptions a year.

    It's not known what the other companies are that Becerra referred to in his tweet. HHS did not immediately respond to a request for comment.

    In July, the agency issued guidance to about 60,000 retail pharmacies that take federal financial assistance from Medicare and Medicaid payments. The agency said these establishments must protect patients’ rights to access reproductive healthcare from a pharmacy, which includes prescription contraceptives.

    This story first appeared in our sister publication, Crain's Chicago Business.

    Related Articles
    Walgreens wanders into the culture wars
    CVS seeks verification on drugs with possible abortion use
    HHS issues HIPAA guidance after abortion ruling
    HHS offers scant details on post-Roe v. Wade strategy
    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    Copy of lab_i.jpg
    FDA eases restrictions on blood donations from gay men
    US-legal-healthcare_i.png
    FTC proposes ban on employee noncompete clauses
    Most Popular
    1
    More healthcare organizations at risk of credit default, Moody's says
    2
    Centene fills out senior executive team with new president, COO
    3
    SCAN, CareOregon plan to merge into the HealthRight Group
    4
    Blue Cross Blue Shield of Michigan unveils big push that lets physicians take on risk, reap rewards
    5
    Bright Health weighs reverse stock split as delisting looms
    Sponsored Content
    Daily Dose Newsletter: Sign up to receive a late afternoon weekday roundup of that day’s breaking news and developments in healthcare.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • COVID-19
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Digital Health
    • Insights
      • ACA 10 Years After
      • Best Practices
      • Special Reports
      • Innovations
    • Opinion
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top 25 Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Supply Chain
        • - Hospital at Home
        • - Workplace of the Future
        • - Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • Data Center
      • Data Center Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • MORE +
      • Contact Us
      • Advertise
      • Media Kit
      • Newsletters
      • Jobs
      • People on the Move
      • Reprints & Licensing